Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L

Journal of Acquired Immune Deficiency Syndromes

Volumn 33, Issue 3, 2003, Pages 300-307

  Pal, Ranajit ^a   Taylor, Brian ^b,c   Foulke, J Scott ^b   Woodward, Ruth ^a   Merges, Michael ^b   Praschunus, Rob ^b   Gibson, Andrew ^a   Reitz, Marvin ^b,c  

^a ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CCR5; Chemokine; Envelope protein; Mucosal transmission; Primate model; SHIV, HIV 1

Indexed keywords

CHEMOKINE RECEPTOR CCR5; RANTES; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ARTICLE; CELL COUNT; CONTROLLED STUDY; ENVELOPE GENE; FEMALE; GENE SEQUENCE; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; SEQUENCE HOMOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS REPLICATION;

EID: 0038163800     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200307010-00003     Document Type: Article

References (34)

1. Letvin NL, King NW. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J Acquir Immune Defic Syndr Hum Retrovirol. 1990;3:1023-1040.
2. Li JT, Halloran M, Lord CI, et al. Persistent infection of macaques with simian-human immunodeficiency viruses. J Virol. 1995;69:7061-7067.
3. Li J, Lord CI, Haseltine W, et al. Infection of cynomolgus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J Acquir Immune Defic Syndr Hum Retrovirol. 1992;5:639-646.
4. Luciw PA, Pratt-Lowe E, Shaw KE, et al. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV). Proc Natl Acad Sci USA. 1995;92:7490-7494.
5. Harouse JM, Gettie A, Tan RC, et al. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science. 1999;284:816-819.
6. Luciw PA, Mandell CP, Himathongkham S, et al. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques. Virology. 1999;263:112-127.
7. Reimann KA, Li JT, Veazey R, et al. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol. 1996;70:6922-6928.
8. Joag SV, Adany I, Li Z, et al. Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS. J Virol. 1997;71:4016-4023.
9. Joag SV, Li Z, Foresman L, et al. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques. AIDS Res Hum Retroviruses. 1997;13:635-645.
10. Karlsson GB, Halloran M, Li J, et al. Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys. J Virol. 1997;71:4218-4225.
11. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science. 1993;261:1179-1181.
12. Schuitemaker H, Kootstra NA, de Goede RE, et al. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J Virol. 1991;65:356-363.
13. Alkhatib G, Combadiere C, Broder CC, et al. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 1996;272:1955-1958.
14. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661-666.
15. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381:667-673.
16. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 1996;85:1135-1148.
17. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 1996;85:1149-1158.
18. Fujisawa J, Seiki M, Kiyokawa T, et al. Functional activation of the long terminal repeat of human T-cell leukemia virus type 1 by a trans-acting factor. Proc Natl Acad Sci USA. 1985;82:2277-2281.
19. Jurriaans S, Van Gemen B, Weverling GJ, et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology. 1994;204:223-233.
20. Tersmette M, de Goede RE, Al BJ, et al. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol. 1988;62:2026-2032.
21. Chen Z, Huang Y, Zhao X, et al. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina). J Virol. 2000;74:6501-6510.
22. Lusso P, Cocchi F, Balotta C, et al. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM-1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J Virol. 1995;69:3712-3720.
23. Layne SP, Merges MJ, Dembo M, et al. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology. 1992;189:695-714.
24. Romano JW, Shurtliff RN, Dobratz E, et al. Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology. J Virol Methods. 2000;86:61-70.
25. Romano JW, Williams KG, Shurtliff RN, et al. NASBA technology: isothermal RNA amplification in qualitative and quatitative diagnostics. Immunol Invest. 1997;26:15-28.
26. Oravecz T, Pall M, Roderiquez G, et al. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med. 1997;186:1865-1872.
27. Iwata S, Yamaguchi N, Munakata Y, et al. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response. Int Immunol. 1999;11:417-426.
28. Proost P, De Meester I, Schols D, et al. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem. 1998;273:7222-7227.
29. Schols D, Proost P, Struyf S, et al. CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity. Antiviral Res. 1998;39:175-187.
30. Struyf S, De Meester I, Scharpe S, et al. Natural truncation of RANTES abolishes signaling through the CC chemokine receptors CCR1 and CCR3, impairs its chemotactic potency and generates a CC chemokine inhibitor. Eur J Immunol. 1998;28:1262-1271.
31. Villinger F, Brice GT, Mayne A, et al. Control mechanisms of virus replication in naturally SIVsmm infected mangabeys and experimentally infected macaques. Immunol Lett. 1999;66:37-46.
32. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load [see comments]. Nat Med. 1996;2:1084-1089.
33. Mascola JR, Stiegler G, VanCott TC, et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med. 2000;6:207-210.
34. Marechal V, Arenzana-Seisdedos F, Heard JM, et al. Opposite effects of SDF-1 on human immunodeficiency virus type 1 replication. J Virol. 1999;73:3608-3615.